Synektik provides market-leading solutions, modern technology and a full range of services and support for medical facilities in the field of radiology. It is Poland's first commercial producer of radiopharmaceuticals used in the diagnosis of cancer. The Company conducts research on its own radiopharmaceutical which applies in cardiology. Synektik has built confidence in the market since 2002. From 2013, it has been listed on the main market of the Warsaw Stock Exchange. In 2011, the company debuted on the NewConnect.